Sanofi India has signed an agreement with India's largest wind turbine manufacturer, Suzlon Energy (SEL), for a 2.1 MW (megawatt) offsite windmill installation, to generate renewable power for captive consumption at its Ankleshwar manufacturing site.
The manufacturing site at Ankieshwar - one of Sanofi's three GIMP (Good Manufacturing Practices) compliant state-of-the-art manufacturing sites in India - produces solid dose formulations and Active Pharma Ingredients (API). Between its two facilities at Goa and Ankleshwar, Sanofi has the capacity to manufacture 8.5 billion tablets annually.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.00 |
| Dr. Reddys Lab | 1215.00 |
| Cipla | 1228.50 |
| Zydus Lifesciences | 927.45 |
| Lupin | 2306.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: